Consortium of Multiple Sclerosis Centers
9
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
22.2%
2 terminated/withdrawn out of 9 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
NARCOMS Registry: A Multiple Sclerosis Registry
Role: collaborator
Effects of Cycling and Virtual Reality on Thinking Speed in Persons With MS (PACE-MS)
Role: collaborator
A Dyadic Approach for Promoting Physical Activity Among People with MS and Their Support Partners
Role: collaborator
Rhythmic Auditory Stimulation & Gait Training
Role: collaborator
Low Load Resistance Training Using Blood Flow Restriction for People With Multiple Sclerosis
Role: collaborator
A Positive Psychology Intervention for Patients With Multiple Sclerosis
Role: collaborator
Treating Anorectal Dysfunction in MS
Role: collaborator
A Study for Testing Text Messaging and Newsletter as a Strategy for Interrupting Sedentary Behavior
Role: collaborator
Oral Testosterone for Fatigue in Male Multiple Sclerosis Patients
Role: collaborator
All 9 trials loaded